过去一年中添加的文章，按日期排序
Adjuvant 5‐fluorouracil and portal vein infusion chemotherapy followed by gemcitabine for pancreatic cancer
M Kitago, Y Endo, K Aiura, Y Takigawa, N Tani… - Cancer …, 2024 - Wiley Online Library
6 天前 - … Pancreatic ductal adenocarcinoma (PDAC) is the 4th … chemotherapy along with
systemic administration of mitomycin … PI4W therapy after curative resection of pancreatic cancer …
systemic administration of mitomycin … PI4W therapy after curative resection of pancreatic cancer …
The Sequencing Conundrum in Localized Pancreatic Adenocarcinoma—Progress or Passive Acceptance?
35 天前 - … ductal adenocarcinoma (PDAC) remains a deadly disease with dismal long-term
outcomes. Multimodality treatment with systemic … resectable pancreatic ductal adenocarcinoma …
outcomes. Multimodality treatment with systemic … resectable pancreatic ductal adenocarcinoma …
Abstract PO2-20-10: Exceptional long-term disease control on pembrolizumab monotherapy in a patient with TMB-high PMS2-mutated MMR-deficient triple negative …
84 天前 - … Biopsy confirmed invasive ductal carcinoma (IDC), grade 1 (G1), ER/PR-positive,
HER2 … resected brain metastasis showed TMB of 48 and MMR deficiency. Therefore, systemic …
HER2 … resected brain metastasis showed TMB of 48 and MMR deficiency. Therefore, systemic …
Perioperative Chemotherapy for Pancreas Cancer: Quo Vadis?
RK Patel, FG Rocha - Annals of Surgical Oncology, 2024 - Springer
93 天前 - … Primary surgical resection alone offers the chance for cure in a small minority of
patients with pancreatic ductal adenocarcinoma (PDAC), because it is an aggressive, systemic …
patients with pancreatic ductal adenocarcinoma (PDAC), because it is an aggressive, systemic …
Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer
H Grauers Wiktorin, E Aydin, R Kiffin, C Vilhav… - Cancer Research …, 2024 - AACR
105 天前 - … cancer [pancreatic ductal adenocarcinoma (PDAC) n = 14, ampullary carcinoma n
= 2, … We report that surgery entails systemic expansion of immunosuppressive M-MDSC that …
= 2, … We report that surgery entails systemic expansion of immunosuppressive M-MDSC that …
[HTML][HTML] Prognostication for recurrence patterns after curative resection for pancreatic ductal adenocarcinoma
A Ang, A Michaelides, C Chelala, D Ullah… - … -Pancreatic Surgery, 2024 - ncbi.nlm.nih.gov
115 天前 - … systematic review has shown that even after surgery, 47%–92% of patients will have
pancreatic ductal adenocarcinoma … This also impacts survival after diagnosis of recurrence …
pancreatic ductal adenocarcinoma … This also impacts survival after diagnosis of recurrence …
Enhancing CAR T cell-based immunotherapy outcomes in PDAC: Evaluating iC9. B7-H3 CAR T cells in adjuvant, neoadjuvant, and monotherapy settings
125 天前 - … : Pancreatic ductal adenocarcinoma (PDAC) is among the most aggressive and
lethal cancers worldwide. Despite negative margin resections and subsequent systemic therapy…
lethal cancers worldwide. Despite negative margin resections and subsequent systemic therapy…
Abstract C027: Perioperative immune perturbations of the metastatic microenvironment in a murine PDAC orthotopic resection model
A Sorrentino, C Alcantara-Hirsch, B Shapiro, E Ma… - Cancer Research, 2024 - AACR
191 天前 - … of treatment for pancreatic ductal adenocarcinoma (PDAC). After “curative intent”
resection, … disease, such as a survival benefit upon resection, systemic disease at the time of …
resection, … disease, such as a survival benefit upon resection, systemic disease at the time of …
Abstract B022: A platform to characterize hepatic immunity reveals variation in hepatic infiltration of tumor expanded T cells in “localized” PDAC
EN Kanu, AA Fletcher, J Bao, AM Eckhoff, K Comatas… - Cancer Research, 2024 - AACR
191 天前 - … earliest stages, pancreatic ductal adenocarcinoma (PDAC… surgery, and these hepatic
metastases dominate survival … a paucity of relevant model systems. To address this deficit, …
metastases dominate survival … a paucity of relevant model systems. To address this deficit, …
Barriers to initiation and completion of adjuvant chemotherapy after resection for pancreatic cancer
Z Sagorin, S Punnen, L Streith, J Li, M Bleszynski… - HPB, 2024 - hpbonline.org
206 天前 - … resectable pancreatic cancer requires resection and systemic chemotherapy for
optimal … pancreatic ductal adenocarcinoma who underwent curative intent surgical resection …
optimal … pancreatic ductal adenocarcinoma who underwent curative intent surgical resection …